Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)piperazin-1-yl-2,2,3,3,5,5,6,6-d8)acetamide dihydrochloride | 1219802-60-4 | 99.0% | 508.51 | 1 MG
Supplier: Medchemexpress LLC HY17401S1MG
Ranolazine-d8 (dihydrochloride) is the deuterium labeled Ranolazine dihydrochloride. Ranolazine dihydrochloride (CVT 303 dihydrochloride) is an anti-angina agent that achieves its effects by inhibiting the late phase of inward sodium current (INa and IKr with IC50 values of 6 μM and 12 μM, respectively) without affecting heart rate or blood pressure (BP). Ranolazine dihydrochloride is also a partial fatty acid oxidation inhibitor. It is for research use only and not sold to patients.
- Isotope-labeled compounds
- Hot research area
- Internal standard for clinical mass spectrometry
- Isotope-labeled inhibitors
- Deuterium (2H, D) stable isotope-labeled inhibitors
- Stable isotope-labeled inhibitors for use in in vivo cell experiments
- Therapeutic drug monitoring: TDM
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?